Institut Jules Bordet

Brussels, Bruxelles-Capitale, Région de 1000

0 studies enrolling now · 1 studies all time

What they study most

Breast Neoplasms, Neoplasm Metastasis

Studies at this site

• A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer — Running, not enrolling